S. B. Zimmerman

736 total citations
18 papers, 546 citations indexed

About

S. B. Zimmerman is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, S. B. Zimmerman has authored 18 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pharmacology and 7 papers in Organic Chemistry. Recurrent topics in S. B. Zimmerman's work include Microbial Natural Products and Biosynthesis (8 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Synthesis and biological activity (2 papers). S. B. Zimmerman is often cited by papers focused on Microbial Natural Products and Biosynthesis (8 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Synthesis and biological activity (2 papers). S. B. Zimmerman collaborates with scholars based in United States, Japan and Germany. S. B. Zimmerman's co-authors include E. O. Stapley, David Hendlin, Sebastian Hernandez, Hiroshi Ōnishi, Sara Currie, S. Mochales, J.M. Mata, M. Jackson, Richard L. Monaghan and H. B. Woodruff and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

S. B. Zimmerman

18 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. B. Zimmerman United States 12 307 268 161 137 46 18 546
Kei-Ichi Fujisawa United Kingdom 13 261 0.9× 299 1.1× 114 0.7× 195 1.4× 38 0.8× 36 604
MIKAO MAYAMA Japan 14 258 0.8× 285 1.1× 94 0.6× 160 1.2× 30 0.7× 35 571
HARUO YAMAMOTO Japan 14 213 0.7× 286 1.1× 81 0.5× 192 1.4× 28 0.6× 30 535
Ryo Okachi Japan 14 327 1.1× 409 1.5× 93 0.6× 250 1.8× 45 1.0× 56 720
J. SCOTT WELLS Malaysia 18 345 1.1× 401 1.5× 163 1.0× 234 1.7× 72 1.6× 28 873
Marlene L. Rathnum Malaysia 12 260 0.8× 247 0.9× 143 0.9× 171 1.2× 115 2.5× 17 634
HIROSHI HINOO Japan 18 294 1.0× 427 1.6× 113 0.7× 155 1.1× 82 1.8× 32 706
JOSEPH O''SULLIVAN Malaysia 16 303 1.0× 336 1.3× 64 0.4× 181 1.3× 54 1.2× 40 660
YUKIMASA NOZAKI Japan 13 245 0.8× 250 0.9× 112 0.7× 156 1.1× 35 0.8× 24 446
Takashi NARA Singapore 13 297 1.0× 425 1.6× 67 0.4× 153 1.1× 51 1.1× 85 667

Countries citing papers authored by S. B. Zimmerman

Since Specialization
Citations

This map shows the geographic impact of S. B. Zimmerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. B. Zimmerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. B. Zimmerman more than expected).

Fields of papers citing papers by S. B. Zimmerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. B. Zimmerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. B. Zimmerman. The network helps show where S. B. Zimmerman may publish in the future.

Co-authorship network of co-authors of S. B. Zimmerman

This figure shows the co-authorship network connecting the top 25 collaborators of S. B. Zimmerman. A scholar is included among the top collaborators of S. B. Zimmerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. B. Zimmerman. S. B. Zimmerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zimmerman, S. B., et al.. (2001). Bacterial degradation of milk components is affected by storage temperature and time. Kansas Agricultural Experiment Station Research Reports. 31–34. 2 indexed citations
2.
Bartlett, John G., Suzanne Bradley, Loreen A. Herwaldt, et al.. (1999). A roundtable discussion of antibiotic resistance: Putting the lessons to work. 106. 6 indexed citations
3.
Gadebusch, H. H., E. O. Stapley, & S. B. Zimmerman. (1992). The Discovery of Cell Wall Active Antibacterial Antibiotics. Critical Reviews in Biotechnology. 12(3). 225–243. 32 indexed citations
4.
Zimmerman, S. B., Cheryl D. Schwartz, Richard L. Monaghan, et al.. (1987). Difficidin and oxydifficidin: Novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis. I.Production, taxonomy and antibacterial activity.. The Journal of Antibiotics. 40(12). 1677–1681. 79 indexed citations
5.
Firestone, Raymond A., Judith M. Pisano, George M Garrity, Robert A. Fromtling, & S. B. Zimmerman. (1987). Lysosomotropic agents. 7. Broad-spectrum antifungal activity of lysosomotropic detergents. Journal of Medicinal Chemistry. 30(8). 1519–1521. 3 indexed citations
6.
KEMPF, AUGUST J., Kenneth E. Wilson, Otto D. Hensens, et al.. (1986). L-681,217, a new and novel member of the efrotomycin family of antibiotics.. The Journal of Antibiotics. 39(10). 1361–1367. 17 indexed citations
7.
Chaiet, Louis, Byron H. Arison, Richard L. Monaghan, et al.. (1984). (R-(Z))-4-amino-3-chloro-2-pentenedioic acid, a new antibiotic. Fermentation, isolation and characterization.. The Journal of Antibiotics. 37(3). 207–210. 13 indexed citations
8.
Gullo, Vincent P., S. B. Zimmerman, Ray S. Dewey, Otto D. Hensens, & Patrick J. Cassidy. (1982). Factumycin, a new antibiotic A40A: fermentation, isolation and antibacterial spectrum.. The Journal of Antibiotics. 35(12). 1705–1707. 26 indexed citations
9.
Stapley, E. O., Patrick J. Cassidy, Josefino B. Tunac, et al.. (1981). Epithienamycins-novel .BETA.-lactams related to thienamycin I. Production and antibacterial activity.. The Journal of Antibiotics. 34(6). 628–636. 35 indexed citations
10.
Girotra, N. N., et al.. (1980). Synthesis and biological activity of flavipucine analogs. Journal of Medicinal Chemistry. 23(2). 209–213. 10 indexed citations
11.
Zimmerman, S. B., John H. Chalmers, Ray S. Dewey, E. O. Stapley, & Sebastian Hernandez. (1979). Heneicomycin, a new antibiotic (A21A): Fermentation, isolation, and antibacterial spectrum.. The Journal of Antibiotics. 32(6). 665–666. 16 indexed citations
12.
Birnbaum, Jerome, E. O. Stapley, A. Kathrine Miller, et al.. (1979). Development of the semisynthetic cephamycin, cefoxitin, as a clinical candidate. Infection. 7(S1). S13–S20. 4 indexed citations
13.
Vandenheuvel, W.J.A., Byron H. Arison, Thomas W. Miller, et al.. (1979). Urinary Metabolites of 3a,4,5,6,7,7a‐Hexahydro‐3‐(1‐methyl‐5‐nitro‐1H‐imidazol‐2‐yl)‐1,2‐benzisoxazole in the Dog. Journal of Pharmaceutical Sciences. 68(9). 1156–1158. 5 indexed citations
14.
Zimmerman, S. B. & E. O. Stapley. (1976). Relative Morphological Effects Induced by Cefoxitin and Other Beta-Lactam Antibiotics In Vitro. Antimicrobial Agents and Chemotherapy. 9(2). 318–326. 14 indexed citations
15.
Ōnishi, Hiroshi, S. B. Zimmerman, & E. O. Stapley. (1974). OBSERVATIONS ON THE MODE OF ACTION OF CEFOXITIN. Annals of the New York Academy of Sciences. 235(1). 406–425. 12 indexed citations
16.
Ōnishi, Hiroshi, et al.. (1974). Cefoxitin, a Semisynthetic Cephamycin Antibiotic: Resistance to Beta-Lactamase Inactivation. Antimicrobial Agents and Chemotherapy. 5(1). 38–48. 120 indexed citations
17.
Stapley, E. O., M. Jackson, Sebastian Hernandez, et al.. (1972). Cephamycins, a New Family of β-Lactam Antibiotics I. Production by Actinomycetes, Including Streptomyces lactamdurans sp. n. Antimicrobial Agents and Chemotherapy. 2(3). 122–131. 126 indexed citations
18.
Wolf, Donald E., et al.. (1970). THE HUMAN TUMOR-EGG HOST SYSTEM. The Journal of Antibiotics. 23(6). 305–310. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kei-Ichi Fujisawa Breakdown of academic impact, for papers by MIKAO MAYAMA Breakdown of academic impact, for papers by HARUO YAMAMOTO Breakdown of academic impact, for papers by Ryo Okachi Breakdown of academic impact, for papers by J. SCOTT WELLS Breakdown of academic impact, for papers by Marlene L. Rathnum Breakdown of academic impact, for papers by HIROSHI HINOO Breakdown of academic impact, for papers by JOSEPH O''SULLIVAN Breakdown of academic impact, for papers by YUKIMASA NOZAKI Breakdown of academic impact, for papers by Takashi NARA
Rankless by CCL
2026